v3.26.3
Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock [Member]
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance at Dec. 31, 2024 $ 19,036 $ 0 $ 1 $ 0 $ 367,318 $ (542) $ (347,741)
Beginning balance (in shares) at Dec. 31, 2024   0 12,853,823 1,076,257      
Shares issued during the period for vested restricted stock awards, shares     209,486        
Issuance of common stock upon exercise of stock options 3       3    
Issuance of common stock upon exercise of stock options, shares     5,000        
Stock-based compensation 280       280    
Net Income (Loss) (3,819)           (3,819)
Other comprehensive gain 28         28  
Ending balance at Mar. 31, 2025 15,528 $ 0 $ 1 $ 0 367,601 (514) (351,560)
Ending balance (in shares) at Mar. 31, 2025   0 13,068,309 1,076,257      
Beginning balance at Dec. 31, 2024 19,036 $ 0 $ 1 $ 0 367,318 (542) (347,741)
Beginning balance (in shares) at Dec. 31, 2024   0 12,853,823 1,076,257      
Issuance of common stock upon exercise of warrants, Value 7,927            
Net Income (Loss) (43,187)            
Ending balance at Sep. 30, 2025 13,732 $ 0 $ 1 $ 0 377,591 (396) (390,928)
Ending balance (in shares) at Sep. 30, 2025   0 14,937,835 1,076,257      
Beginning balance at Mar. 31, 2025 15,528 $ 0 $ 1 $ 0 367,601 (514) (351,560)
Beginning balance (in shares) at Mar. 31, 2025   0 13,068,309 1,076,257      
Shares issued during the period for vested restricted stock awards, shares     53,708        
Issuance of common stock upon exercise of stock options 7,927       7,927    
Issuance of common stock upon exercise of stock options, shares     1,750,000        
Stock-based compensation 936       936    
Net Income (Loss) (15,430)           (15,430)
Other comprehensive gain 81         81  
Ending balance at Jun. 30, 2025 9,042 $ 0 $ 1 $ 0 376,464 (433) (366,990)
Ending balance (in shares) at Jun. 30, 2025   0 14,872,017 1,076,257      
Shares issued during the period for vested restricted stock awards, shares     65,818        
Stock-based compensation 1,127       1,127    
Net Income (Loss) (23,938)           (23,938)
Other comprehensive gain 37         37  
Ending balance at Sep. 30, 2025 13,732 $ 0 $ 1 $ 0 377,591 (396) (390,928)
Ending balance (in shares) at Sep. 30, 2025   0 14,937,835 1,076,257      
Beginning balance at Dec. 31, 2025 (42,958) $ 0 $ 2 $ 0 384,648 (290) (427,318)
Beginning balance (in shares) at Dec. 31, 2025   0 15,537,344 1,076,257      
Shares issued during the period for vested restricted stock awards, shares     112,286        
Sale of shares 805       805    
Sale of shares, shares     168,700        
Stock offering costs (31)       (31)    
Stock-based compensation 3,337       3,337    
Net Income (Loss) 32,599           32,599
Other comprehensive gain 99         99  
Ending balance at Mar. 31, 2026 (6,149) $ 0 $ 2 $ 0 388,759 (191) (394,719)
Ending balance (in shares) at Mar. 31, 2026   0 15,818,330 1,076,257      
Beginning balance at Dec. 31, 2025 (42,958) $ 0 $ 2 $ 0 384,648 (290) (427,318)
Beginning balance (in shares) at Dec. 31, 2025   0 15,537,344 1,076,257      
Issuance of common stock upon exercise of warrants, Value 2,023            
Sale of shares     $ 1,900        
Sale of shares, shares     859,190        
Net Income (Loss) 12,177            
Ending balance at Sep. 30, 2026 (17,415) $ 0 $ 2 $ 0 397,686 38 (415,141)
Ending balance (in shares) at Sep. 30, 2026   0 18,152,140 1,076,257      
Beginning balance at Mar. 31, 2026 (6,149) $ 0 $ 2 $ 0 388,759 (191) (394,719)
Beginning balance (in shares) at Mar. 31, 2026   0 15,818,330 1,076,257      
Shares issued during the period for vested restricted stock awards, shares     455,969        
Sale of shares 667       667    
Sale of shares, shares     181,452        
Stock offering costs (25)       (25)    
Stock-based compensation 2,166       2,166    
Net Income (Loss) (27,124)           (27,124)
Other comprehensive gain 119         119  
Ending balance at Jun. 30, 2026 (30,346) $ 0 $ 2 $ 0 391,567 (72) (421,843)
Ending balance (in shares) at Jun. 30, 2026   0 16,455,751 1,076,257      
Shares issued during the period for vested restricted stock awards, shares     74,052        
Issuance of common stock upon exercise of stock options, shares     17,117        
Issuance of common stock upon exercise of warrants, Shares     685,885        
Issuance of common stock upon exercise of warrants, Value 2,023       2,023    
Sale of shares 1,863       1,863    
Sale of shares, shares     859,190        
Stock offering costs (39)       (39)    
Stock-based compensation 2,101       2,101    
Net Income (Loss) 6,702           6,702
Other comprehensive gain 110         110  
Commitment shares issued for equity line of credit     60,145        
Commitment shares issued for equity line of credit 171       171    
Ending balance at Sep. 30, 2026 $ (17,415) $ 0 $ 2 $ 0 $ 397,686 $ 38 $ (415,141)
Ending balance (in shares) at Sep. 30, 2026   0 18,152,140 1,076,257